-
Subject Areas on Research
-
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.
-
A Pilot Randomized Trial of Ferric Citrate Coordination Complex for the Treatment of Advanced CKD.
-
A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
-
A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia.
-
AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia.
-
An assessment of medical resource utilization and hospitalization cost associated with a diagnosis of anemia in women with obstetrical bleeding in the United States.
-
Anemia and coronary artery disease: pathophysiology, prognosis, and treatment.
-
Association of blood donation with iron deficiency among adolescent and adult females in the United States: a nationally representative study.
-
Cases from the Osler Medical Service at Johns Hopkins University. Diffuse colonic angiodysplasia with chronic iron deficiency anemia.
-
Caught on Capsule: Iron-deficiency Anemia Due to Hookworm Infection.
-
Commentary on: ferrokinetics in the syndrome of familial hypoferremic microcytic anemia with iron malabsorption.
-
Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates.
-
Detection of iron deficiency in children with Down syndrome.
-
Disorders of iron metabolism.
-
Donor Iron Deficiency Study (DIDS): protocol of a study to test whether iron deficiency in blood donors affects red blood cell recovery after transfusion.
-
Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis.
-
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials.
-
Effects of ferric carboxymaltose on markers of mineral and bone metabolism: A single-center prospective observational study of women with iron deficiency.
-
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women.
-
Efficacy of iron-supplement bars to reduce anemia in urban Indian women: a cluster-randomized controlled trial.
-
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis.
-
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial.
-
GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.
-
Hair Mercury Level is Associated with Anemia and Micronutrient Status in Children Living Near Artisanal and Small-Scale Gold Mining in the Peruvian Amazon.
-
Health, nutrition and prosperity: a microeconomic perspective.
-
Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation.
-
Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum.
-
Household food insecurity is a risk factor for iron-deficiency anaemia in a multi-ethnic, low-income sample of infants and toddlers.
-
How do I develop a process to effectively treat parturients with iron deficiency anemia?
-
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis.
-
Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management.
-
Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial.
-
Improved Hemoglobin Response with Ferric Carboxymaltose in Patients with Gastrointestinal-Related Iron-Deficiency Anemia Versus Oral Iron.
-
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease.
-
Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome.
-
Iron Deficiency Anemia in Pregnancy.
-
Iron deficiency and hair loss: the jury is still out.
-
Iron deficiency in female pattern hair loss, chronic telogen effluvium, and control groups.
-
Iron deficiency in young Lebanese children: association with elevated blood lead levels.
-
Iron deficiency: lessons from anemic mice.
-
Iron metabolism: iron deficiency and iron overload.
-
Management of Perioperative Iron Deficiency in Cardiac Surgery: A Modified RAND Delphi Study.
-
Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men with Unexplained or Iron-Deficiency Anemia.
-
Maternal Perceived Stress during Pregnancy Increases Risk for Low Neonatal Iron at Delivery and Depletion of Storage Iron at One Year.
-
Modulation of sulfur assimilation metabolic toxicity overcomes anemia and hemochromatosis in mice.
-
Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA).
-
Nutrition and hearing loss: a neglected cause and global health burden.
-
Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure.
-
Patient Blood Management: Recommendations From the 2018 Frankfurt Consensus Conference.
-
Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish Heart Failure Registry.
-
Prevalence of iron deficiency in children with Down syndrome.
-
Proinflammatory state, hepcidin, and anemia in older persons.
-
Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design.
-
Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
-
Randomized trial of intravenous iron-induced hypophosphatemia.
-
Response to Zhang et al.
-
Review: In HF with iron deficiency, iron supplementation reduces HF admissions and improves cardiac function.
-
Risk Factors for and Effects of Persistent and Severe Hypophosphatemia Following Ferric Carboxymaltose.
-
Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
-
Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials.
-
Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.
-
The association between serum copper and anaemia in the adult Second National Health and Nutrition Examination Survey (NHANES II) population.
-
The interaction among sex, hemoglobin and outcomes in a specialty heart failure clinic.
-
The molecular regulation of iron metabolism.
-
Treatment of iron deficiency anemia: are monomeric iron compounds suitable for parenteral administration?